Search clinical trials for: Carfilzomib, Lenalidomide, Dexamethasone, Belantamab Mafodotin
Total 501 results
-
Novartis PharmaceuticalsWithdrawn
-
PfizerRecruitingMultiple MyelomaUnited States, Canada
-
Mayo ClinicNational Cancer Institute (NCI)Completed
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Completed
-
Novartis PharmaceuticalsTerminated
-
Boston Medical CenterCompletedMultiple MyelomaUnited States
-
CelgeneCompletedMultiple MyelomaUnited States, Canada
-
Bristol-Myers SquibbAbbVieCompletedLymphoma | Multiple MyelomaUnited States, Belgium, France, Germany, Italy, Japan, United Kingdom, Australia, Poland, Puerto Rico, Canada, Denmark, Hungary, Israel, Spain, Czechia, Ireland, Austria, Switzerland, Greece, Turkey, Romania, United Arab Emirates
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Belgium, Canada, France, Germany, Italy, Japan, Netherlands, Norway, Spain, Sweden, Switzerland, United Kingdom
-
AmgenCompletedMultiple MyelomaKorea, Republic of, Spain, Taiwan, Canada, Australia, Israel, Italy, United States, Singapore, New Zealand, Japan, Thailand, Brazil, United Kingdom, Hungary, Czechia, Romania, Slovakia, France, Germany, Russian Federation, Bulgaria, Belgiu... and more
-
Emory UniversityAmgenCompletedNeoplasms | MalignanciesUnited States
-
Karyopharm Therapeutics IncWithdrawnMultiple MyelomaUnited States
-
CelgeneCompleted
-
Celgene CorporationCompletedRelapsed or Refractory Multiple MyelomaGermany
-
IRCCS Policlinico S. MatteoCelgene CorporationCompleted
-
National Cancer Institute (NCI)RecruitingPlasmacytoma | Refractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
Stichting Hemato-Oncologie voor Volwassenen NederlandNot yet recruiting
-
Attaya SuvannasankhaJanssen Scientific Affairs, LLC; Indiana Institute for Medical ResearchWithdrawnMultiple MyelomaUnited States
-
National University Hospital, SingaporeCelgene; International Myeloma Foundation; The Australasian Leukaemia & Lymphoma...UnknownRelapsed and/or Refractory Multiple MyelomaSingapore, Hong Kong, Korea, Republic of, Taiwan
-
Mayo ClinicNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.; Biologics,...Active, not recruitingSolitary Osseous PlasmacytomaUnited States
-
Weill Medical College of Cornell UniversityCelgene CorporationCompletedMultiple MyelomaUnited States
-
Cancer Trials IrelandSanofi; Dana-Farber Cancer InstituteRecruitingMultiple MyelomaDenmark, Ireland
-
Thomas Martin, MDSanofi; AmgenActive, not recruitingMultiple MyelomaUnited States, Canada
-
AmgenCompletedRefractory Multiple Myeloma | Relapsed Multiple MyelomaCanada, Belgium, Spain, United States, Korea, Republic of, Australia, Czechia, Taiwan, Hungary, Austria, Romania, Japan, United Kingdom, Greece, Turkey, Bulgaria, France, Russian Federation, Poland
-
Bristol-Myers SquibbRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Austria, Denmark, Canada, Australia, China, Spain, Germany, United Kingdom, Hungary, Taiwan, Israel, Japan, India, Norway, Brazil, Italy, Greece, Korea, Republic of, Colombia, Singapore, Netherlands, Argentina, Hong Kong, Romani... and more
-
University of Alabama at BirminghamAmgenCompletedPhase 2 Trial of Carfilzomib for Metastatic Castration-resistant Prostate Cancer Following TreatmentMetastatic Castration-resistant Prostate CancerUnited States
-
Cancer Trials IrelandCompleted
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham... and other collaboratorsActive, not recruitingMultiple MyelomaUnited States
-
SanofiCompleted
-
Sun Yat-sen UniversityRecruitingMyeloma | Newly Diagnosed | High RiskChina
-
Hackensack Meridian HealthMerck Sharp & Dohme LLCCompletedMultiple MyelomaUnited States
-
Intergroupe Francophone du MyelomeCompleted
-
The First Hospital of Jilin UniversityUnknownMultiple Myeloma in RelapseChina
-
University of ChicagoNational Cancer Institute (NCI)RecruitingRefractory Multiple MyelomaUnited States
-
Tel-Aviv Sourasky Medical CenterWeizmann Institute of ScienceRecruitingMultiple Myeloma in Relapse | Multiple Myeloma, RefractoryIsrael
-
US Oncology ResearchKaryopharm Therapeutics IncRecruitingMultiple Myeloma | Plasma Cell Myeloma | Myeloma-Multiple | Myeloma Multiple | Kahler Disease | Myeloma, Plasma Cell | MyelomatosisUnited States
-
National Cancer Institute (NCI)CompletedStage II Multiple Myeloma | Stage III Multiple Myeloma | Multiple Myeloma in RelapseUnited States
-
National Cancer Institute (NCI)Active, not recruitingRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
Arbeitsgemeinschaft medikamentoese TumortherapieMedical University of Vienna; Sanofi; Assign Data Management and Biostatistics... and other collaboratorsRecruitingNewly Diagnosed Multiple MyelomaAustria, Greece, Serbia
-
The First Affiliated Hospital of Soochow UniversityThe First Affiliated Hospital with Nanjing Medical University; Jiangsu Province... and other collaboratorsRecruiting
-
Weill Medical College of Cornell UniversityCelgeneCompletedMultiple MyelomaUnited States
-
National Cancer Institute (NCI)TerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States, South Africa
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Australia, Canada, France, Germany, Israel, Italy, Japan, Netherlands, Spain, United Kingdom
-
Hackensack Meridian HealthOnyx Therapeutics, Inc.CompletedWaldenstrom MacroglobulinemiaUnited States
-
Dana-Farber Cancer InstituteAmgenCompletedWaldenstrom's MacroglobulinemiaUnited States
-
Mayo ClinicCompletedRefractory Multiple MyelomaUnited States
-
Xia ZhongjunAntengene CorporationRecruiting
-
University of ChicagoNational Cancer Institute (NCI); Multiple Myeloma Research FoundationRecruitingMultiple MyelomaUnited States, Canada
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States